TABLE 2:

Values for regional CBF, CBV, CMRO2, OEF, and CBF/CBV ratio of patients and control subjects

Value	Ipsilateral Side to the Vascular Lesion					Contralateral Side to the Vascular Lesion
Value	Hemisphere	Anterior BZ	Posterior BZ	Internal BZ	MCA Territory	Hemisphere	Anterior BZ	Posterior BZ	Internal BZ	Non-BZ
CBF (mL/100 g/min)
Control	47.5 ± 9.4	44.0 ± 8.1	45.9 ± 9.2	43.1 ± 12.9	53.6 ± 11.9	47.5 ± 9.4	44.0 ± 8.1	45.9 ± 9.2	43.1 ± 12.9	53.6 ± 11.9
ICA stenosis	35.1 ± 6.1^*	29.7 ± 5.0^*	32.5 ± 6.1^*	28.6 ± 5.8^*	38.4 ± 8.0^*	37.8 ± 5.2^*	32.3 ± 4.6^*	34.9 ± 5.5^*	30.4 ± 3.4^*	43.2 ± 7.2
ICA occlusion	30.7 ± 5.5^*	26.5 ± 6.3^*	30.7 ± 4.5^*	26.9 ± 5.7^*	31.8 ± 7.0^*	34.3 ± 4.4^*	30.7 ± 4.7^*	32.6 ± 7.0^*	29.2 ± 3.1^*	37.7 ± 5.9^*
MCA lesion	35.4 ± 3.4^*	31.2 ± 4.0^*	33.1 ± 3.3^*	29.9 ± 4.8^*	36.6 ± 4.6^*	38.6 ± 4.6	33.5 ± 4.3^*	36.5 ± 5.9	33.2 ± 7.0	41.7 ± 4.9
CBV (mL/100 g)
Control	3.64 ± 0.41	3.06 ± 0.60	3.47 ± 0.40	2.45 ± 0.51	4.08 ± 0.53	3.64 ± 0.41	3.06 ± 0.60	3.47 ± 0.40	2.45 ± 0.51	4.08 ± 0.53
ICA stenosis	3.41 ± 0.46	2.67 ± 0.60	2.94 ± 0.76	2.51 ± 0.76	3.72 ± 0.62	3.35 ± 0.40	2.55 ± 0.42	3.16 ± 0.61	2.42 ± 0.55	3.79 ± 0.34
ICA occlusion	4.04 ± 0.91	3.24 ± 1.10	3.37 ± 0.70	3.34 ± 0.98	3.99 ± 0.88	3.37 ± 0.34	2.58 ± 0.71	3.31 ± 0.66	2.64 ± 0.66	3.32 ± 0.35^*
MCA lesion	3.65 ± 0.39	2.94 ± 0.52	3.33 ± 0.56	2.87 ± 1.28	3.93 ± 0.52	3.55 ± 0.65	3.00 ± 0.35	2.83 ± 0.95	2.78 ± 0.47	3.67 ± 0.39
CMRO₂ (mL/100 g/min)
Control	34.0 ± 0.46	31.5 ± 5.1	35.8 ± 4.9	29.8 ± 5.5	37.7 ± 4.3	34.0 ± 0.46	31.5 ± 5.1	35.8 ± 4.9	29.8 ± 5.5	37.7 ± 4.3
ICA stenosis	25.9 ± 2.6^*	22.2 ± 2.9^*	25.6 ± 4.4^*	21.3 ± 3.3^*	28.2 ± 3.0^*	27.9 ± 3.3^*	24.1 ± 3.0^*	27.0 ± 4.4^*	23.4 ± 3.3^*	31.7 ± 4.6
ICA occlusion	27.3 ± 2.7^*	22.8 ± 3.2^*	29.0 ± 2.7^*	23.3 ± 4.3	28.9 ± 3.4^*	29.2 ± 1.8	26.3 ± 3.3	28.6 ± 3.4^*	24.8 ± 1.4	32.2 ± 3.2
MCA lesion	27.2 ± 2.2^*	23.5 ± 1.7^*	26.7 ± 3.3^*	22.4 ± 3.9^*	28.9 ± 4.2^*	29.2 ± 1.7^*	24.3 ± 2.5^*	28.8 ± 2.2^*	24.2 ± 2.7^*	33.4 ± 5.5
OEF
Control	41.9 ± 6.4	42.0 ± 7.5	45.2 ± 5.8	41.0 ± 6.3	41.4 ± 6.7	41.9 ± 6.4	42.0 ± 7.5	45.2 ± 5.8	41.0 ± 6.3	41.4 ± 6.7
ICA stenosis	47.1 ± 6.5	48.6 ± 8.0	49.8 ± 7.9	48.5 ± 8.1	46.2 ± 6.1	46.4 ± 5.7	47.5 ± 7.0	48.0 ± 7.1	47.6 ± 5.4	45.7 ± 5.4
ICA occlusion	53.7 ± 5.4^*	52.2 ± 4.8	56.5 ± 4.9^*	52.6 ± 5.7^*	54.4 ± 6.9^*	51.1 ± 2.8^*	51.1 ± 3.1	52.9 ± 4.7	50.3 ± 3.0	50.9 ± 2.9^*
MCA lesion	48.8 ± 5.1	49.0 ± 5.4	50.7 ± 5.7	48.7 ± 5.1	49.4 ± 5.4	47.3 ± 5.8	46.0 ± 6.3	50.8 ± 5.8	48.5 ± 7.4	46.8 ± 6.1
CBF/CBV ratio (/min)
Control	0.078 ± 0.016	0.071 ± 0.016	0.078 ± 0.013	0.060 ± 0.014	0.078 ± 0.013	0.078 ± 0.016	0.071 ± 0.016	0.078 ± 0.013	0.060 ± 0.014	0.078 ± 0.013
ICA stenosis	0.101 ± 0.019	0.093 ± 0.019	0.098 ± 0.036	0.090 ± 0.026	0.101 ± 0.024	0.093 ± 0.022	0.084 ± 0.018	0.096 ± 0.026	0.080 ± 0.024	0.093 ± 0.025
ICA occlusion	0.135 ± 0.039^*	0.130 ± 0.049^*	0.111 ± 0.037	0.121 ± 0.036^*	0.130 ± 0.032^*	0.101 ± 0.018	0.088 ± 0.028	0.108 ± 0.025	0.088 ± 0.023	0.090 ± 0.015
MCA lesion	0.106 ± 0.016	0.099 ± 0.023	0.102 ± 0.021	0.100 ± 0.039	0.111 ± 0.020	0.095 ± 0.014	0.092 ± 0.014	0.080 ± 0.031	0.090 ± 0.020	0.091 ± 0.013

Note.—Values are the mean ± SD.
* P < .05, different from control as determined by means of ANOVA with the Scheffé F test.